Victoria Socha

DocwireNews

Kidney transplant recipients are at increased risk of severe disease and death related to COVID-19. There are few data available on the evolution of graft function among kidney transplant recipients hospitalized with COVID-19 who survive the infection.Gina Defelice, MD, and colleagues conducted a study among adult kidney transplant recipients at a single transplant center who were diagnosed with COVID-19 and hospitalized between March 5, 2020, and January 15, 2021. Results were reported in Cureus [doi:10.7759.cureus.31375].The analysis included patient demographics, comorbid risk factors, and inpatient clinical courses for patients who recovered from the infection. Kidney function was measured preinfection, during the initial hospitalization, and up to 12 months postinfection.During the study period, 48 kidney transplant recipients were diagnosed with COVID-19 infection. Of those, 18 required hospitalization for symptoms of fever and respiratory distress. Four of the 18 patients died from complications related to COVID-19.Of the 14 remaining patients, 85.7% were Black, and median time from transplant was 4 years. Of the analysis cohort, 64.3% developed acute kidney injury (AKI), with an average peak serum creatinine of 2.6 mg/dL and an average glomerular filtration rate (GFR) of 35 mL/min/1.73 m2. Prior to infection, the mean serum creatinine was 2 mg/dL and mean GFR was 44 mL/min1.73 m2, representing an increase in serum creatinine of 34% and a decrease in GFR of 29%.Mean follow-up postinfection was 14.5 months. At 3 to 6 months postinfection, mean serum creatinine was 1.87 mg/dL and mean GFR was 47 mL/min/1.73 m2. At 9 to 12 months postinfection, the values were 1.89 mg/dL and 48 mL/min/1.73 m2.Five of the 14 patients developed new onset proteinuria (36%); all had complete resolution at 3 to 6 months of follow-up. Among the patients who developed AKI, 78% had complete recovery at 3 to 6 months of follow-up.One patient experienced graft loss. That patient had a baseline serum creatinine of 3.8 mg/dL and GFR of 22 mL/min/1.73 m2, existing proteinuria on urinalysis, and a history of biopsy-proven rejection.&ldquo;AKI is common among kidney transplant recipients who are hospitalized with COVID-19 infection,&rdquo; the researchers said. &ldquo;Most of these recovered, although we noted that patients with baseline lower kidney function and existing proteinuria had a lower recovery rate.&rdquo;

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

COVID-19 Outcomes in Kidney Transplant Recipients

COVID-19 and Kidney Disease

The evolution of graft function among kidney transplant recipients hospitalized with COVID-19 who survive the infection.

COVID-19 in kidney transplant recipients

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe